GS

Ghanshyam Sharma

Active Director Director DIN 08694583
DIN 08694583 First appointment Feb 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Ghanshyam Sharma

Data last updated:

Ghanshyam Sharma is a Director at Asitang Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare.

DIN 08694583
Primary Designation Director
Industry Healthcare
First Appointment 10 Feb 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Feb 20202020Active

Board colleagues of Ghanshyam Sharma

NameDINCompanyDesignation
Gorakh Nath Sharma08694542Asitang Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Asitang Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ghanshyam Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ghanshyam Sharma

Ghanshyam Sharma currently holds 1 directorship: Asitang Pharmaceuticals Private Limited (Director, since 10 Feb 2020).

Ghanshyam Sharma was first appointed on 10 Feb 2020 as Director at Asitang Pharmaceuticals Private Limited.

The current boards of Ghanshyam Sharma's companies include Gorakh Nath Sharma (Asitang Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available